Pages that link to "Q42655664"

The following pages link to Fluoxetine in the prevention of depressive recurrences: a double-blind study. (Q42655664):

Displaying 22 items.

• Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants (Q24624760) (← links)
• Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (Q28088645) (← links)
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre (Q31121202) (← links)
• Continuation treatment of major depressive disorder: is there a case for duloxetine? (Q33755767) (← links)
• Studies of long-term use of antidepressants: how should the data from them be interpreted? (Q34148012) (← links)
• Australian and New Zealand clinical practice guidelines for the treatment of depression (Q34548787) (← links)
• Preventing relapse and recurrence of depression: a brief review of therapeutic options. (Q34587416) (← links)
• Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis (Q35066804) (← links)
• Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression (Q35098031) (← links)
• The pharmacological management of depression (Q35236630) (← links)
• World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. (Q35560309) (← links)
• A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. (Q35680384) (← links)
• An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder (Q35746646) (← links)
• Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study (Q37154799) (← links)
• Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression. (Q37605157) (← links)
• Meta-analysis of relapse prevention antidepressant trials in depressive disorders (Q37773366) (← links)
• Neurobiological mechanisms of stress resilience and implications for the aged population. (Q39311440) (← links)
• Relapse rates with long-term antidepressant drug therapy: a meta-analysis (Q39971035) (← links)
• Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study. (Q40263403) (← links)
• Prophylactic Ketamine Treatment Promotes Resilience to Chronic Stress and Accelerates Recovery: Correlation with Changes in Synaptic Plasticity in the CA3 Subregion of the Hippocampus (Q64066957) (← links)
• Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves (Q96162477) (← links)
• Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis (Q97681346) (← links)